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Turner syndrome (TS), a chronic childhood disease, requires growth hormone (GH) treatment 
for short stature in pediatrics and sex hormone replacement therapy (HRT) in the adult health-
care setting with transition during adolescence managed by gynecologists or endocrinologists (1). 
However, many women with TS are reported to be receiving inadequate health care. Only 24 of 39 
(63%) TS patients received regular follow-up in an Australian study (2), and 13 of 102 were lost to 
follow-up in a Belgian study (3). Thus, the current management of transition of TS patients seems to 
be inadequate. This is because there are limited numbers of gynecologists or endocrinologists who 
are familiar with adult TS, and a reliable management plan for TS during transition has not yet been 
fully established.
Turner syndrome women with complete or partial deletion of an X chromosome will develop 
various complications in each life stage (Figure  1). In addition to short stature, cardiovascular 
disease, kidney disease, and otitis media are often observed in childhood. GH therapy is performed 
for short stature in childhood and in adolescence they require HRT to acquire secondary sexual 
characteristics due to ovarian dysfunction. In adulthood, ovarian dysfunction causes infertility and 
osteoporosis. Endocrine/metabolic abnormalities, such as thyroid dysfunction, impaired glucose 
tolerance, hypertension, dyslipidemia, and gonadal tumors due to Y chromosome components are 
also observed. Therefore, all health problems that present during childhood should be followed-up 
in later life.
In our department, health management of TS adults is performed in Women’s Health Care Clinic 
by gynecologists who are familiar with the above conditions. Women’s health problems, due to the 
female-specific endocrine environment, change throughout every life stage (4). The salient points 
for TS health management are (1) commencement of HRT for ovarian dysfunction, (2) management 
of childhood onset complications, and (3) screening for complications that may develop in adult-
hood. At every visit, blood pressure and body weight were measured. Blood liver function, renal 
function, glucose tolerance, lipids, thyroid function, and urine analysis were measured once a year. 
Bone mineral density, ultrasound measurement of uterine size, and aortic MRI were performed at 
first visit. When a complication developed in a patient, she was referred to the relevant health-care 
professionals. Gawlik and Malecka-Tendera (5) have also demonstrated that all medical problems 
that present during childhood should be followed in adult life, with particular importance assigned 
to screening for hypertension, diabetes mellitus, dyslipidaemia, and osteoporosis.
It has been recommended in the guidelines (1) that transition care should be continued up to 
18 years of age before transfer to adult health care, in which a gynecologist who is familiar with 
the unique problems of TS adults, such as ovarian dysfunction and infertility, is involved. HRT is 
recommended to start at 12–15 years old. However, in our department, the age at completion of GH 
therapy, in patients referred from pediatrics, was 17.7 ± 2.1 years old, the age of commencement of 
HRT was 17.9 ± 2.2 years of age, and the age at the time of transition was 23.4 ± 4.1 years of age. 
Figure 1 | Complications in women with TS.
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On the other hand, in survivors of childhood cancer, the starting 
age for HRT was 14.1 ± 1.2 years of age and the age of transition 
was 14.5 ± 1.9 years old (6). Our data shows that transition was 
not fully completed, although HRT was initiated and GH therapy 
had been completed. The transition from pediatrics was later than 
that recommended because of a delay in the end of GH therapy 
and initiation of HRT.
Since there is a lifetime increased risk of complications in TS 
women, the needs for a systematic and holistic approach in the 
provision of health care and the establishment of an optimal model 
of transition to adult health care in TS women are essential (7). A 
pediatric gynecology clinic was opened in Kanagawa Children’s 
Medical Center for the management of HRT in childhood and to 
ensure a smooth transition to our department from the time of 
GH therapy completion to starting HRT.
We conclude that in the future, gynecologists should be more 
involved in coordinating the initiation of HRT in order to create 
a smoother transition from pediatrics to adult health care for the 
management of women with TS.
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